Your browser doesn't support javascript.
loading
Saxagliptin combined with additional oral antihyperglycaemic agents in drug-naive diabetic patients with high glycosylated haemoglobin: A 24-week, multicentre, randomized, open-label, active parallel-controlled group clinical trial in China (SUCCESS).
Chen, Xiaoping; Jiang, Hongwei; Li, Hongmei; Kuang, Hongyu; Chen, Li; Ma, Jianhua; Zhang, Qiu; Pan, Tianrong; Yang, Wenying.
Afiliación
  • Chen X; Department of Endocrinology, China-Japan Friendship Hospital, Beijing, People's Republic of China.
  • Jiang H; Department of Endocrinology, The First Affiliated Hospital of Henan University of Science & Technology, Luoyang, People's Republic of China.
  • Li H; Department of Endocrinology, Emergency General Hospital, Beijing, People's Republic of China.
  • Kuang H; Department of Endocrinology, The First Affiliated Hospital of Harbin Medical University, Harbin, People's Republic of China.
  • Chen L; Department of Endocrinology, Qilu Hospital of Shandong University, Jinan, People's Republic of China.
  • Ma J; Department of Endocrinology, Nanjing First Hospital, Nanjing, People's Republic of China.
  • Zhang Q; Department of Endocrinology, The First Affiliated Hospital of Anhui Medical University, Hefei, People's Republic of China.
  • Pan T; Department of Endocrinology, The Second Affiliated Hospital of Anhui Medical University, Hefei, People's Republic of China.
  • Yang W; Department of Endocrinology, China-Japan Friendship Hospital, Beijing, People's Republic of China.
Diabetes Obes Metab ; 25(1): 272-281, 2023 01.
Article en En | MEDLINE | ID: mdl-36099069

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Inhibidores de la Dipeptidil-Peptidasa IV Tipo de estudio: Clinical_trials Límite: Humans País/Región como asunto: Asia Idioma: En Revista: Diabetes Obes Metab Asunto de la revista: ENDOCRINOLOGIA / METABOLISMO Año: 2023 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Inhibidores de la Dipeptidil-Peptidasa IV Tipo de estudio: Clinical_trials Límite: Humans País/Región como asunto: Asia Idioma: En Revista: Diabetes Obes Metab Asunto de la revista: ENDOCRINOLOGIA / METABOLISMO Año: 2023 Tipo del documento: Article